CohBar, Inc.
(NASDAQ : CWBR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.29%183.301.3%$478.93m
ARRYArray BioPharma Inc.
0.01%46.518.1%$426.58m
CELGCelgene Corporation
0.27%98.091.3%$407.13m
GILDGilead Sciences, Inc.
0.06%68.300.9%$393.75m
BIIBBiogen Inc.
0.31%234.631.3%$351.79m
ILMNIllumina, Inc.
0.99%355.433.5%$285.01m
REGNRegeneron Pharmaceuticals, Inc.
2.85%319.682.6%$240.04m
VRTXVertex Pharmaceuticals Incorporated
0.34%182.371.9%$217.45m
AAgilent Technologies, Inc.
0.14%72.751.6%$195.49m
EXASExact Sciences Corporation
-0.63%115.2624.1%$187.97m
ALXNAlexion Pharmaceuticals, Inc.
2.80%127.232.0%$182.95m
BMRNBioMarin Pharmaceutical Inc.
1.55%86.344.3%$129.82m
SRPTSarepta Therapeutics, Inc.
-3.09%130.2614.7%$108.90m
INCYIncyte Corporation
1.43%86.082.5%$107.96m
MRTXMirati Therapeutics Inc.
4.40%105.682.5%$102.72m

Company Profile

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.